Bone health in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED): findings in 25 adults

Clinical Endocrinology
O MäkitieJ Perheentupa

Abstract

Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) is characterized by chronic mucocutaneous candidiasis and autoimmune destruction of endocrine organs. The resulting endocrinopathies and their treatment may impact bone health. The purpose of our study was to assess bone health and its correlates in adult patients with APECED. Twenty-five adults (12 males) with APECED were prospectively assessed. Data on their previous medical history were collected from hospital records. Areal bone mineral density (aBMD) for the lumbar spine (L1-L4), femoral neck and whole body as well as volumetric BMD (vBMD) for the lumbar spine (L2-L4) were measured with dual-energy X-ray absorptiometry (DXA). Mean age was 34 years (range 21-59 years). All patients had 1-4 autoimmune endocrinopathies, the most common being adrenocortical failure (20 patients) and hypoparathyroidism (18 patients). Osteopaenia or osteoporosis was present in 28%. The median (range) aBMD Z-scores were for the lumbar spine -0.3 (-2.3 to +3.3) and for the femoral neck, -0.1 (-2.2 to +2.0). The BMD Z-scores tended to be higher in patients with hypoparathyroidism than in patients with normal parathyroid function (at the lumbar spine +0.4 vs.-1.2, P = 0.016, and...Continue Reading

References

May 1, 1990·Acta paediatrica Scandinavica·R SorvaJ Perheentupa
Feb 9, 2000·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·G D BraatvedtI R Reid
Nov 8, 2001·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·C J Lamberg-AllardtL M Valsta
May 28, 2002·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·M R RubinJ P Bilezikian
Jul 3, 2002·Endocrinology and Metabolism Clinics of North America·Jaakko Perheentupa
Nov 27, 2002·The American Journal of Clinical Nutrition·Marjo K M Lehtonen-VeromaaJorma S A Viikari
Mar 4, 2003·Nature Immunology·Adrian ListonChristopher C Goodnow
Apr 18, 2003·Clinical Endocrinology·Esteban JódarFederico Hawkins
Oct 15, 2003·The Journal of Clinical Endocrinology and Metabolism·Mikhail GyllingAaro Miettinen
Jan 13, 2004·The Journal of Clinical Endocrinology and Metabolism·Ville-Valtteri VälimäkiMatti J Välimäki
Feb 4, 2005·Endocrine Reviews·Johannes D VeldhuisCyril Y Bowers
Mar 5, 2005·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·Francine N TonRobert M Neer

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Polyendocrine Syndromes

This feed focuses on a rare genetic condition called Autoimmune Polyendocrine Syndromes, which are characterized by autoantibodies against multiple endocrine organs. This can lead to Type I Diabetes.

Autoimmune Polyendocrinopathies

Autoimmune polyendocrinopathies, also called polyglandular autoimmune syndromes (PGASs), or polyendocrine autoimmune syndromes(PASs), are a heterogeneous group of rare diseases characterized by autoimmune activity against more than one endocrine organ, although non-endocrine organs can be affected. Discover the latest research on autoimmune polyendocrinopathies here.

© 2022 Meta ULC. All rights reserved